Download PDFPDF

Nasal/buccal midazolam use in the community
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Buccal midazolam

    This seems to be a reasonable alternate to rectal diazepam, however there is a diffrence in the setting where both can be compare. In the hand of medical and paramedical personnel, buccal Midazolam will be more easier to use but the rectal diazepam suppository is more handy and user friendly if to be used by lay person or the parents.

    Conflict of Interest:
    None declared.
  • Published on:
    Community use of buccal midazolam
    • Jane L Dunlop, Paediatric Specialist Registrar
    • Other Contributors:
      • Andrew W McNinch

    Dear Editor

    This report is welcome in providing data on the important subject of buccal midazolam use in the community. Confidence in the results would be increased by clarification of the following points:

    First, might the parents have been biased in favour of midazolam by the package of education and discussion about potential benefits which preceded the midazolam usage?

    Second,it would be...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Precautions with buccal/nasal midazolam
    • Sudhir Kumar, Consultant Neurologist, Department of Neurological Sciences

    Dear Editor

    I read with great interest the recent article entitled "nasal/buccal midazolam use in the community".[1] However, I would like to point out a few precautions.

    Wilson et al. have used nasal/buccal midazolam for prolonged seizures including status epilepticus. However, in a recent study,[2] the efficacy of buccal midazolam in treating status epilepticus was found to be only 50% and convuls...

    Show More
    Conflict of Interest:
    None declared.